Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lysosomes and unfolded protein response, determinants of differential resistance of melanoma cells to vinca alkaloids

Identifieur interne : 000F45 ( Main/Exploration ); précédent : 000F44; suivant : 000F46

Lysosomes and unfolded protein response, determinants of differential resistance of melanoma cells to vinca alkaloids

Auteurs : Laure-Anais Vincent [France] ; Chaker Attaoua [France] ; Michel Bellis [France] ; Lucie Rozkydalova [France, République tchèque] ; Kamel Hadj-Kaddour [France] ; Laurence Vian [France] ; Pierre Cuq [France]

Source :

RBID : ISTEX:77B006757A459C9E70C35165922D5B5A52AAF069

Abstract

On account of its strong ability to become chemoresistant after a primary response to drugs, malignant melanoma (MM) remains a therapeutic challenge. This study focuses on acquired resistance to vinca alkaloids (VAs) using VA‐resistant MM cell lines (CAL1R‐VCR, CAL1R‐VDS, and CAL1R‐VRB), established by long‐term continuous exposure of parental CAL1‐wt cells to vincristine (VCR), vindesine (VDS), or vinorelbine (VRB), respectively. Transcriptomic profiling using rma and rdam methods led to distinguish two cell groups: CAL1R‐VCR and CAL1R‐VDS, CAL1R‐VRB, and CAL1‐wt. mgsa of the specifically altered genes in the first group evidenced the GO terms ‘lysosomal lumen’ and ‘vacuolar lumen’ linked to underexpressed genes, and ‘endoplasmic reticulum (ER) stress response’ associated with overexpressed genes. A specific reduction of lysosomal enzymes, independent of acidic vacuole organelle (AVO) turnover, was observed (LTG probe) in CAL1R‐VCR and CAL1R‐VDS cells. It was associated with the specific lowering of cathepsin B and L, known to be involved in the lysosomal pathway of apoptosis. Confirming gene profiling, the same groups (CAL1R‐VCR and CAL1R‐VDS, CAL1‐wt and CAL1R‐VRB) could be distinguished regarding the VA‐mediated changes on mean size areas and on acidic compartment volumes. These two parameters were reduced in CAL1R‐VCR and CAL1R‐VDS cells, suggesting a smaller AVO accumulation and thus a reduced sensitivity to lysosomal membrane permeabilization‐mediated apoptosis. In addition, ‘ER stress response’ inhibition by tauroursodeoxycholic acid induced a higher VA sensitization of the first cell group. In conclusion, lysosomes and unfolded protein response could be key determinants of the differential resistance of MM to VAs.

Url:
DOI: 10.1111/fcp.12098


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lysosomes and unfolded protein response, determinants of differential resistance of melanoma cells to vinca alkaloids</title>
<author>
<name sortKey="Vincent, Laure Nais" sort="Vincent, Laure Nais" uniqKey="Vincent L" first="Laure-Anais" last="Vincent">Laure-Anais Vincent</name>
</author>
<author>
<name sortKey="Attaoua, Chaker" sort="Attaoua, Chaker" uniqKey="Attaoua C" first="Chaker" last="Attaoua">Chaker Attaoua</name>
</author>
<author>
<name sortKey="Bellis, Michel" sort="Bellis, Michel" uniqKey="Bellis M" first="Michel" last="Bellis">Michel Bellis</name>
</author>
<author>
<name sortKey="Rozkydalova, Lucie" sort="Rozkydalova, Lucie" uniqKey="Rozkydalova L" first="Lucie" last="Rozkydalova">Lucie Rozkydalova</name>
</author>
<author>
<name sortKey="Hadj Addour, Kamel" sort="Hadj Addour, Kamel" uniqKey="Hadj Addour K" first="Kamel" last="Hadj-Kaddour">Kamel Hadj-Kaddour</name>
</author>
<author>
<name sortKey="Vian, Laurence" sort="Vian, Laurence" uniqKey="Vian L" first="Laurence" last="Vian">Laurence Vian</name>
</author>
<author>
<name sortKey="Cuq, Pierre" sort="Cuq, Pierre" uniqKey="Cuq P" first="Pierre" last="Cuq">Pierre Cuq</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:77B006757A459C9E70C35165922D5B5A52AAF069</idno>
<date when="2015" year="2015">2015</date>
<idno type="doi">10.1111/fcp.12098</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-6QP0CWZN-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000804</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000804</idno>
<idno type="wicri:Area/Istex/Curation">000804</idno>
<idno type="wicri:Area/Istex/Checkpoint">000090</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000090</idno>
<idno type="wicri:doubleKey">0767-3981:2015:Vincent L:lysosomes:and:unfolded</idno>
<idno type="wicri:Area/Main/Merge">000F46</idno>
<idno type="wicri:Area/Main/Curation">000F45</idno>
<idno type="wicri:Area/Main/Exploration">000F45</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Lysosomes and unfolded protein response, determinants of differential resistance of melanoma cells to vinca alkaloids</title>
<author>
<name sortKey="Vincent, Laure Nais" sort="Vincent, Laure Nais" uniqKey="Vincent L" first="Laure-Anais" last="Vincent">Laure-Anais Vincent</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Toxicologie du Médicament, Institut des Biomolécules Max Mousseron (UMR5247), UFR des Sciences Pharmaceutiques et Biologiques, Université de Montpellier, 15 Avenue Charles Flahault, BP14491, 34093, Montpellier Cedex 05</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Attaoua, Chaker" sort="Attaoua, Chaker" uniqKey="Attaoua C" first="Chaker" last="Attaoua">Chaker Attaoua</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Toxicologie du Médicament, Institut des Biomolécules Max Mousseron (UMR5247), UFR des Sciences Pharmaceutiques et Biologiques, Université de Montpellier, 15 Avenue Charles Flahault, BP14491, 34093, Montpellier Cedex 05</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bellis, Michel" sort="Bellis, Michel" uniqKey="Bellis M" first="Michel" last="Bellis">Michel Bellis</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre de Recherche de Biochimie Macromoléculaire (CRBM), UMR 5237, CNRS, 1919 Route de Mende, 34293, Montpellier Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rozkydalova, Lucie" sort="Rozkydalova, Lucie" uniqKey="Rozkydalova L" first="Lucie" last="Rozkydalova">Lucie Rozkydalova</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Toxicologie du Médicament, Institut des Biomolécules Max Mousseron (UMR5247), UFR des Sciences Pharmaceutiques et Biologiques, Université de Montpellier, 15 Avenue Charles Flahault, BP14491, 34093, Montpellier Cedex 05</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05, Hradec Kralove</wicri:regionArea>
<wicri:noRegion>Hradec Kralove</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hadj Addour, Kamel" sort="Hadj Addour, Kamel" uniqKey="Hadj Addour K" first="Kamel" last="Hadj-Kaddour">Kamel Hadj-Kaddour</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Toxicologie du Médicament, Institut des Biomolécules Max Mousseron (UMR5247), UFR des Sciences Pharmaceutiques et Biologiques, Université de Montpellier, 15 Avenue Charles Flahault, BP14491, 34093, Montpellier Cedex 05</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Vian, Laurence" sort="Vian, Laurence" uniqKey="Vian L" first="Laurence" last="Vian">Laurence Vian</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Toxicologie du Médicament, Institut des Biomolécules Max Mousseron (UMR5247), UFR des Sciences Pharmaceutiques et Biologiques, Université de Montpellier, 15 Avenue Charles Flahault, BP14491, 34093, Montpellier Cedex 05</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cuq, Pierre" sort="Cuq, Pierre" uniqKey="Cuq P" first="Pierre" last="Cuq">Pierre Cuq</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Toxicologie du Médicament, Institut des Biomolécules Max Mousseron (UMR5247), UFR des Sciences Pharmaceutiques et Biologiques, Université de Montpellier, 15 Avenue Charles Flahault, BP14491, 34093, Montpellier Cedex 05</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">France</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Fundamental & Clinical Pharmacology</title>
<title level="j" type="alt">FUNDAMENTAL AND CLINICAL PHARMACOLOGY</title>
<idno type="ISSN">0767-3981</idno>
<idno type="eISSN">1472-8206</idno>
<imprint>
<biblScope unit="vol">29</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="164">164</biblScope>
<biblScope unit="page" to="177">177</biblScope>
<biblScope unit="page-count">14</biblScope>
<date type="published" when="2015-04">2015-04</date>
</imprint>
<idno type="ISSN">0767-3981</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0767-3981</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">On account of its strong ability to become chemoresistant after a primary response to drugs, malignant melanoma (MM) remains a therapeutic challenge. This study focuses on acquired resistance to vinca alkaloids (VAs) using VA‐resistant MM cell lines (CAL1R‐VCR, CAL1R‐VDS, and CAL1R‐VRB), established by long‐term continuous exposure of parental CAL1‐wt cells to vincristine (VCR), vindesine (VDS), or vinorelbine (VRB), respectively. Transcriptomic profiling using rma and rdam methods led to distinguish two cell groups: CAL1R‐VCR and CAL1R‐VDS, CAL1R‐VRB, and CAL1‐wt. mgsa of the specifically altered genes in the first group evidenced the GO terms ‘lysosomal lumen’ and ‘vacuolar lumen’ linked to underexpressed genes, and ‘endoplasmic reticulum (ER) stress response’ associated with overexpressed genes. A specific reduction of lysosomal enzymes, independent of acidic vacuole organelle (AVO) turnover, was observed (LTG probe) in CAL1R‐VCR and CAL1R‐VDS cells. It was associated with the specific lowering of cathepsin B and L, known to be involved in the lysosomal pathway of apoptosis. Confirming gene profiling, the same groups (CAL1R‐VCR and CAL1R‐VDS, CAL1‐wt and CAL1R‐VRB) could be distinguished regarding the VA‐mediated changes on mean size areas and on acidic compartment volumes. These two parameters were reduced in CAL1R‐VCR and CAL1R‐VDS cells, suggesting a smaller AVO accumulation and thus a reduced sensitivity to lysosomal membrane permeabilization‐mediated apoptosis. In addition, ‘ER stress response’ inhibition by tauroursodeoxycholic acid induced a higher VA sensitization of the first cell group. In conclusion, lysosomes and unfolded protein response could be key determinants of the differential resistance of MM to VAs.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>République tchèque</li>
</country>
<region>
<li>Languedoc-Roussillon</li>
<li>Occitanie (région administrative)</li>
</region>
<settlement>
<li>Montpellier</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Occitanie (région administrative)">
<name sortKey="Vincent, Laure Nais" sort="Vincent, Laure Nais" uniqKey="Vincent L" first="Laure-Anais" last="Vincent">Laure-Anais Vincent</name>
</region>
<name sortKey="Attaoua, Chaker" sort="Attaoua, Chaker" uniqKey="Attaoua C" first="Chaker" last="Attaoua">Chaker Attaoua</name>
<name sortKey="Bellis, Michel" sort="Bellis, Michel" uniqKey="Bellis M" first="Michel" last="Bellis">Michel Bellis</name>
<name sortKey="Cuq, Pierre" sort="Cuq, Pierre" uniqKey="Cuq P" first="Pierre" last="Cuq">Pierre Cuq</name>
<name sortKey="Cuq, Pierre" sort="Cuq, Pierre" uniqKey="Cuq P" first="Pierre" last="Cuq">Pierre Cuq</name>
<name sortKey="Hadj Addour, Kamel" sort="Hadj Addour, Kamel" uniqKey="Hadj Addour K" first="Kamel" last="Hadj-Kaddour">Kamel Hadj-Kaddour</name>
<name sortKey="Rozkydalova, Lucie" sort="Rozkydalova, Lucie" uniqKey="Rozkydalova L" first="Lucie" last="Rozkydalova">Lucie Rozkydalova</name>
<name sortKey="Vian, Laurence" sort="Vian, Laurence" uniqKey="Vian L" first="Laurence" last="Vian">Laurence Vian</name>
</country>
<country name="République tchèque">
<noRegion>
<name sortKey="Rozkydalova, Lucie" sort="Rozkydalova, Lucie" uniqKey="Rozkydalova L" first="Lucie" last="Rozkydalova">Lucie Rozkydalova</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F45 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F45 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:77B006757A459C9E70C35165922D5B5A52AAF069
   |texte=   Lysosomes and unfolded protein response, determinants of differential resistance of melanoma cells to vinca alkaloids
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021